Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12094-009-0379-x.pdf
Reference38 articles.
1. Grahovac G, Tomac D, Lambasa S et al (2009) Cerebellar glioblastomas: pathophysiology, clinical presentation and management. Acta Neurochir (Wien) Mar 25 [Epub ahead of print]
2. Luccarelli G (1980) Glioblastoma multiforme of the cerebellum: description of three cases. Acta Neurochir (Wien) 53:107–116
3. Hur H, Jung S, Jung TY, Kim IY (2008) Cerebellar glioblastoma multiforme in an adult. J Korean Neurosurg Soc 43:194–197
4. Muñoz M, Rosso M (2009) The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest New Drugs Jan 17 [Epub ahead of print]
5. Ekinci N, Acer N, Akkaya A et al (2008) Volumetric evaluation of the relations among the cerebrum, cerebellum and brain stem in young subjects: a combination of stereology and magnetic resonance imaging. Surg Radiol Anat 30:489–494
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive;International Journal of Molecular Sciences;2023-10-23
2. Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature;Cancers;2022-12-28
3. Cerebellar anaplastic astrocytoma in adult patients: 15 consecutive cases from a single institution and literature review;Journal of Clinical Neuroscience;2021-09
4. Cerebellar anaplastic astrocytoma in adult patients: 15 consecutive cases from a single institution and literature review;2020-09-14
5. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma;Neuro-Oncology;2018-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3